HOME >> BIOLOGY >> NEWS
Towards a cheap and easy way to monitor HIV/AIDS

Doctors regularly monitor the level of an immune cell in the blood called a CD4 cell in HIV-infected individuals, to decide when to start treatment and when to change medications. Unfortunately, the existing reliable CD4 counters are large and expensive pieces of equipment, and every actual count is not only expensive but also requires considerable expertise. These tools are therefore unsuitable for many low-income countries.

William Rodriguez and colleagues now report a new way of counting CD4 cells that is cheaper and easier than the current state-of-the-art technology. As they describe in the July issue of the international medical journal PLoS Medicine, their prototype performed well when tested on real-life samples, mostly from adult patients. Its reliability was as good as the existing counters in the range of counts where CD4 numbers are most critical to inform treatment decisions. A fully portable handheld model is now under development. After some modest training, such a tool should allow a variety of health care workers in remote areas to accurately analyze the CD4 status of HIV infected patients locally.

In an accompanying Perspective article, Zvi Bentwich (of Hebrew University in Jerusalem) argues that "the absence of tools to measure CD4 counts clearly jeopardizes the success of recently launched global campaigns to fight AIDS". While acknowledging that several issues remain to be resolved before the assay can become a widely used tool in resource-poor settings, Bentwich states "the authors of this study should be commended for addressing an extremely important issue and developing this novel approach for counting CD4 in patients with HIV."


'"/>

Contact: Paul Ocampo
press@plos.org
415-624-1224
Public Library of Science
18-Jul-2005


Page: 1

Related biology news :

1. Dengue and other hemorrhagic fevers: Towards a first potential treatment
2. Towards predicting late-stage radiation toxicity
3. Towards the mechanism of cell respiration
4. Towards a unified model of transcription termination
5. Towards targeted lung cancer treatment
6. New grants bolster efforts to generate faster and cheaper tools for DNA sequencing
7. CESAR could hail cheaper and greener small aircraft
8. The power of one: A simpler, cheaper method for cell fusion
9. Producing flu vaccines will be faster and cheaper, thanks to MSU technology
10. Research milestone brings goal closer of cheap antimalarial drug for developing world
11. Quicker, cheaper DNA sequencing goal of UH profs with $4.2 million NIH grant

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Towards cheap and easy way monitor HIV AIDS

(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Iris Biometrics - Global Strategic Business Report" report ... markets for Iris Biometrics in US$ Thousands. The report provides ... , Japan , Europe ... , and Latin America . ...
(Date:3/17/2015)... 17, 2015  MecklerMedia Corporation (OTCQX: MECK) announced ... service robots ever held in New ... May 11-13, 2015 at the Javits Convention Center. ... event include: Acorn Product Development; Axis NJ; c-Link ... Robotics; Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; ...
(Date:3/12/2015)... MOUNTAIN VIEW, Calif. , March 12, 2015 ... EDTLOCATION:Online, with Complimentary Registration here: http://bit.ly/1G7Os0L . ... Program Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... future in order to compete in several different ... the market is currently witnessing an uptrend. ...
Breaking Biology News(10 mins):Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
(Date:3/30/2015)... With recent advancements in residential solar ... major companies are getting into the Solar Energy wave. ... for renewable energy production, many homeowners are looking to ... is a new solar distribution company in California which ... qualifying homeowners to enjoy the benefits of solar energy ...
(Date:3/30/2015)... , March 30, 2015  Heidrick & Struggles (Nasdaq: ... , leadership consulting and culture shaping ... the firm to lead its global Healthcare and Life Sciences ... and Life Sciences, Mitchell will lead a team of more ... Europe and Asia ...
(Date:3/30/2015)... , March 30, 2015 US-Australian drug discovery ... its subsidiary, CanTx, Inc., and Yale University, on March ... The data was presented as an oral presentation by ... Medical School to the 62 nd Annual Scientific ... San Francisco, CA. In ...
(Date:3/30/2015)... , March 30, 2015    Intrexon ... in synthetic biology, and Merck Serono, the biopharmaceutical ... , today announced an exclusive strategic collaboration ... Antigen Receptor T-cell (CAR-T) cancer therapies. This collaboration ... innovative therapies that modulate the immune system,s natural ...
Breaking Biology Technology:Solara Power Announces Residential Solar Power with No Up-Front Fees 2Heidrick & Struggles Strengthens Leadership of Healthcare - Life Sciences Practice 2Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4
Cached News: